Süleyman Çağan Efe
@scaganefe
cardiologist & life long learner & AFL04 & AUTF10 & Kosuyolu Heart Education and Research Hospital
13-06-2013 10:29:31
654 Tweets
919 Followers
747 Following
#DANGERSHOCK trial
Percutaneous microaxial flow pumps can reduce all-cause mortality in AMI-CS.
- 14% risk reduction and NNT of 8. Increased risk for bleeding, limb ischemia and need for RRT #ACC24 Turkish Society of Cardiology
